Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT
Blood Research
;
: S75-S78, 2022.
Article
in English
| WPRIM
| ID: wpr-925625
ABSTRACT
The accurate assessment of initial disease status and therapeutic responses is critical to the optimal management of patients with lymphoma. Currently, staging and treatment response evaluation for lymphoma has been standardized into the Lugano classification. Lugano classification incorporates positron emission tomography (PET) into the existing response criteria, and response assessment using FDG-PET/CT has been proven to predict the prognosis in various lymphoma subtypes effectively. We will briefly review the current staging and response evaluation system and explore the role of functional imaging in the field of lymphoma.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
English
Journal:
Blood Research
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS